• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Eli Lilly increases access to clinical trials data for qualified researchers

Eli Lilly increases access to clinical trials data for qualified researchers

June 2, 2014
CenterWatch Staff

Eli Lilly will begin sharing its clinical trial data with scientific researchers through www.clinicalstudydatarequest.com. This web site, which houses data from several trial sponsors, was created in support of ongoing efforts by the Pharmaceutical Research and Manufacturers of America (PhRMA) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) to increase access to and transparency of clinical trial results with researchers around the world.

Tim Garnett, M.D., senior vice president and chief medical officer, Eli Lilly, said, "By joining others in our industry to share clinical trial data with qualified researchers, we can quicken the pace of scientific advances needed to make life better."

The new portal differs from previous Lilly data-sharing sites in that access will be granted only after approval of a research proposal by an independent scientific review panel. Lilly will not be involved in the decisions made by the independent panel.

The multi-sponsor portal will include Lilly-sponsored interventional clinical studies from approved medicines and indications in the U.S. and E.U. in the following categories:

  • phase II, III or IV studies used as part of a regulatory approval submitted to the FDA on or after 1999;
  • phase II, III or IV global studies with a first patient visit after Jan. 1, 2007; and
  • phase II, III or IV global or regional/local studies in indications approved in both the U.S. and E.U. with a first patient visit after Jan. 1, 2014.

All shared data on the web site are anonymized to safeguard patients' privacy.

As part of Lilly's commitment to open access and transparency, the company established a web site in January to facilitate researchers' requests for data from interventional clinical trials for approved medicines and indications. However, this web site was an interim solution as Lilly worked with others in the pharmaceutical industry to create coordinated access to data from multiple study sponsors. Now that this coordinated access is available, Lilly will replace the current web site with the newly announced site.

Lilly also provides information on and links to information about our clinical studies on www.lillytrials.com. The web site includes results of all Lilly-sponsored phase II, phase III and phase IV clinical trials, as well as observational trials of Lilly-marketed products conducted anywhere in the world that were initiated on or after Oct. 15, 2002.

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing